↓ Skip to main content

Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study

Overview of attention for article published in Frontiers in Molecular Biosciences, January 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
57 Dimensions

Readers on

mendeley
14 Mendeley